Sustainability | December 17, 2025
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
The net-zero target approval complements the company's near-term emission reduction targets
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Reinforcing commitment to ethical and sustainable growth
The agreement complements other PPAs for Sandoz production sites globally
Subscribe To Our Newsletter & Stay Updated
